Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 22


Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations.

Liu L, Mo Z, Liang Z, Zhang Y, Li R, Ong KC, Wong KT, Yang E, Che Y, Wang J, Dong C, Feng M, Pu J, Wang L, Liao Y, Jiang L, Tan SH, David P, Huang T, Zhou Z, Wang X, Xia J, Guo L, Wang L, Xie Z, Cui W, Mao Q, Liang Y, Zhao H, Na R, Cui P, Shi H, Wang J, Li Q.

BMC Med. 2015 Sep 17;13:226. doi: 10.1186/s12916-015-0448-7.


Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in Chinese healthy population aged >2 years: A randomized, double-blinded, active control, phase III trial.

Kong Y, Zhang W, Jiang Z, Wang L, Li C, Li Y, Xia J.

Hum Vaccin Immunother. 2015 Oct 3;11(10):2425-33. doi: 10.1080/21645515.2015.1055429.


Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency.

Niebur HB, Duff CM, Shear GF, Nguyen D, Alberdi TK, Dorsey MJ, Sleasman JW.

Clin Exp Immunol. 2015 Sep;181(3):441-50. doi: 10.1111/cei.12623. Epub 2015 Jul 7.


Clinical characteristics of adults with chronic rhinosinusitis and specific antibody deficiency.

Kashani S, Carr TF, Grammer LC, Schleimer RP, Hulse KE, Kato A, Kern RC, Conley DB, Chandra RK, Tan BK, Peters AT.

J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):236-42. doi: 10.1016/j.jaip.2014.09.022. Epub 2014 Nov 25.


Development of Streptococcus pneumoniae Vaccines Using Live Vectors.

Wang S, Curtiss R 3rd.

Vaccines (Basel). 2014 Jan 7;2(1):49-88.


Comparison of diagnostic criteria for common variable immunodeficiency disorder.

Ameratunga R, Brewerton M, Slade C, Jordan A, Gillis D, Steele R, Koopmans W, Woon ST.

Front Immunol. 2014 Sep 15;5:415. doi: 10.3389/fimmu.2014.00415. eCollection 2014. Review.


Pneumococcal vaccines: understanding centers for disease control and prevention recommendations.

Mirsaeidi M, Schraufnagel DE.

Ann Am Thorac Soc. 2014 Jul;11(6):980-5. doi: 10.1513/AnnalsATS.201401-042CME.


Dectin-2-dependent NKT cell activation and serotype-specific antibody production in mice immunized with pneumococcal polysaccharide vaccine.

Miyasaka T, Akahori Y, Toyama M, Miyamura N, Ishii K, Saijo S, Iwakura Y, Kinjo Y, Miyazaki Y, Oishi K, Kawakami K.

PLoS One. 2013 Oct 25;8(10):e78611. doi: 10.1371/journal.pone.0078611. eCollection 2013.


Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19⁺CD20⁺CD3⁻CD70⁻CD27⁺IgM⁺CD43⁺CD5⁺/⁻.

Leggat DJ, Khaskhely NM, Iyer AS, Mosakowski J, Thompson RS, Weinandy JD, Westerink MA.

Vaccine. 2013 Sep 23;31(41):4632-40. doi: 10.1016/j.vaccine.2013.07.030. Epub 2013 Aug 1.


New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.

Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R.

Clin Exp Immunol. 2013 Nov;174(2):203-11. doi: 10.1111/cei.12178. Review.


Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.

Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Saez M, Soldevila N, Astray J, Mayoral JM, Martín V, Quintana JM, González-Candelas F, Galán JC, Tamames S, Castro A, Baricot M, Garín O, Pumarola T; CIBERESP Cases and Controls in Pandemic Influenza Working Group (Spain).

Hum Vaccin Immunother. 2013 Apr;9(4):865-73. doi: 10.4161/hv.23090. Epub 2013 Apr 1.


Modeling of cost effectiveness of pneumococcal conjugate vaccination strategies in U.S. older adults.

Smith KJ, Wateska AR, Nowalk MP, Raymund M, Lee BY, Zimmerman RK.

Am J Prev Med. 2013 Apr;44(4):373-81. doi: 10.1016/j.amepre.2012.11.035.


Pneumonia immunization in older adults: review of vaccine effectiveness and strategies.

Assaad U, El-Masri I, Porhomayon J, El-Solh AA.

Clin Interv Aging. 2012;7:453-61. doi: 10.2147/CIA.S29675. Epub 2012 Nov 1. Review.


Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients.

Tobudic S, Plunger V, Sunder-Plassmann G, Riegersperger M, Burgmann H.

PLoS One. 2012;7(9):e46133. doi: 10.1371/journal.pone.0046133. Epub 2012 Sep 28.


Antibody persistence in mothers one year after pneumococcal immunization in pregnancy.

Schlaudecker EP, Steinhoff MC, Omer SB, Roy E, Arifeen SE, Dodd CN, Altaye M, Raqib R, Breiman RF, Zaman K.

Vaccine. 2012 Jul 20;30(34):5063-6. doi: 10.1016/j.vaccine.2012.06.003. Epub 2012 Jun 16.


Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.

Westerink MA, Schroeder HW Jr, Nahm MH.

Aging Dis. 2012 Feb;3(1):51-67. Epub 2011 Jul 20.


Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells.

Clutterbuck EA, Lazarus R, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, Pollard AJ.

J Infect Dis. 2012 May 1;205(9):1408-16. doi: 10.1093/infdis/jis212. Epub 2012 Mar 29.


Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals.

Nunes MC, Madhi SA.

Hum Vaccin Immunother. 2012 Feb;8(2):161-73. doi: 10.4161/hv.18432. Epub 2012 Feb 1. Review.


Characterization of specific antibody deficiency in adults with medically refractory chronic rhinosinusitis.

Carr TF, Koterba AP, Chandra R, Grammer LC, Conley DB, Harris KE, Kern R, Schleimer RP, Peters AT.

Am J Rhinol Allergy. 2011 Jul-Aug;25(4):241-4. doi: 10.2500/ajra.2011.25.3653.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk